Jacobson Resonance Enterprises, Inc. Announces 10-KSB Update


BOYNTON BEACH, Fla., April 14, 2003 (PRIMEZONE) -- Jacobson Resonance Enterprises Inc., (OTCBB:JRSE) announces today that the year-end filing for 2002 (10-KSB) will be delayed from its original extended deadline of Tuesday, April 15, 2003.

Dr. Jerry I. Jacobson, Chairman and Chief Executive Officer, said: "Delays in connection with the year-end audit are the result of our changing our independent public accountants."

The Company's 10-KSB is expected to be edgarized and filed with the Securities and Exchange Commission within 30 days of the extension date.

JRSE is an emerging worldwide leader in magnetic resonance technology, whose main focus is the eradication of human suffering. The Company's technology base has the potential for multiple industry applications including the fields of medicine, food and beverage, pharmaceuticals, construction and the environment.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The matters covered by such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements of the Company to differ materially from those contemplated or implied by such forward-looking statements. For further information, contact Harvey Grossman at (561) 752.4141.



            

Contact Data